戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hyperkinetic states such as those induced by stimulant drugs.
2                                 Increases in stimulant drug abuse may increase the rate of hospital a
3  underlying neurocognitive endophenotype for stimulant drug addiction.
4 that repeated treatment with the psychomotor stimulant drug amphetamine, which produces robust sensit
5 hown the safety and effectiveness of new non-stimulant drugs and long-acting formulations of methylph
6 sting target for a modulation of response to stimulant drugs and other striatal-based behavior.
7 unctional circuits in individuals exposed to stimulant drugs both with and without clinically diagnos
8        Clandestine chemists synthesize novel stimulant drugs by exploiting structural templates known
9  in intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine).
10 ongoing dual opioid/stimulant crisis, rising stimulant drug deaths, and demand for effective treatmen
11 lated on brain abnormalities associated with stimulant drug dependence.
12 the NAcc not only in the generation of acute stimulant drug effects but in sensitized responding to t
13     The research began with the finding that stimulant drugs enhanced memory in rats when administere
14 ectional designs, and without accounting for stimulant drug exposure.
15 ty and were not predicted by past or present stimulant drug exposure.
16 icated as mediating the rewarding effects of stimulant drugs; however, recent studies suggest that 5-
17 m may account for the therapeutic effects of stimulant drugs in clinical disorders such as ADHD.
18                             Amphetamine-like stimulant drugs, including MDMA, do not seem to act by r
19                                 The abuse of stimulant drugs is increasing in the western United Stat
20 reas transporter-mediated release induced by stimulant drugs is more restricted and unlikely to occur
21              Further, co-use of opioids with stimulants drugs is common, and the opioid supply is unp
22   The authors investigated the effect of the stimulant drug methylphenidate (given intravenously) on
23 itive to endogenous dopamine) induced by the stimulant drug methylphenidate in 20 controls and 20 det
24  how expectation affects the response to the stimulant drug methylphenidate in 25 cocaine abusers.
25  further highlighted by the finding that the stimulant drug methylphenidate mitigated the hyperactivi
26 ility in the left ventral striatum, and that stimulant drugs modulate impulsivity and striatal D2/3 r
27 e administration of the first MPH dose to 40 stimulant drug-naive boys newly diagnosed with ADHD whil
28 l FH of substance use disorders (n = 16); 2) stimulant drug-naive healthy control subjects with no kn
29  (17 male, 7 female; age 23.0 +/- 6.2 years) stimulant drug-naive subjects who underwent PET [(11)C]r
30                                              Stimulant drugs of abuse have several effects on neural
31 city, promoting, for example, the actions of stimulant drugs of abuse such as cocaine.
32 eak link in the neurotoxicity seen following stimulant drugs of abuse.
33  shared by individuals who were dependent on stimulant drugs or used cocaine recreationally.
34                                              Stimulant drugs such as amphetamine are readily self-adm
35                                              Stimulant drugs such as cocaine and amphetamine have a h
36 exual desire could be one mechanism by which stimulant drugs such as cocaine and methamphetamine incr
37  seen in only a fraction of those exposed to stimulant drugs such as cocaine.
38                     The rewarding effects of stimulant drugs such as methylphenidate (MP) depend cruc
39                           However, newer non-stimulant drugs, such as atomoxetine and guanfacine, sug
40 uspected category of nitromethane precursor: stimulant drugs, such as ephedrine and methamphetamine,
41 ales to overdose deaths caused by opioid and stimulant drugs, taking into account differing state-lev
42                                              Stimulant drugs that boost dopamine, like methylphenidat
43  it so there is concern about treatment with stimulant drugs: this fear appears not to be substantiat
44          Exclusion criteria included current stimulant drug treatment, current moderate to severe sym
45 protected vaginal intercourse (p = 0.026) or stimulant drug use (p = 0.026), and more likely to repor
46 ey also reported significantly fewer days of stimulant drug use during the 3-month follow-up.
47 as associated with increased abstinence from stimulant drug use in stimulant-dependent patients with
48 ssue diseases, portal hypertension, diet and stimulant drug use, HIV infection, and congenital heart
49 vulnerability for dependence or with regular stimulant drug use.
50                                              Stimulant drug visits increased from 0.57 million to 2.8
51            Ephedrine and pseudoephedrine are stimulant drugs whose use is prohibited in athletic comp
52  function predict that the neural effects of stimulant drugs will vary according to task requirements